Drug Search Results
More Filters [+]

AdimFlu-S

Alternative Names: AdimFlu-S
Latest Update: 2023-07-10
Latest Update Note: News Article

Product Description

Mechanisms of Action: Vaccine

Novel Mechanism: No

Modality: Vaccine

Route of Administration: Intramuscular

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Adimmune
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for AdimFlu-S

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Influenza, Human|Kidney Failure, Chronic

Phase 3: Influenza, Human

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

2016-001557-41

P3

Completed

Influenza, Human

2017-09-05

ADIMQIS20160328

P3

Completed

Influenza, Human

2017-07-12

25%

A-BR-101-139

P4

Unknown status

Influenza, Human|Kidney Failure, Chronic

2014-06-01

FLU12T13A

P4

Completed

Influenza, Human

2012-08-01

Recent News Events